Ping Zhan

4.9k total citations
166 papers, 3.6k citations indexed

About

Ping Zhan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Ping Zhan has authored 166 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 62 papers in Oncology and 42 papers in Epidemiology. Recurrent topics in Ping Zhan's work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (25 papers) and Fungal Infections and Studies (24 papers). Ping Zhan is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (25 papers) and Fungal Infections and Studies (24 papers). Ping Zhan collaborates with scholars based in China, Netherlands and United States. Ping Zhan's co-authors include Yong Song, Tangfeng Lv, Weida Liu, Li Yu, Bing Wan, Qian Qian, Li‐Xin Qiu, Yanan Ji, Hongbing Liu and Suhua Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Ping Zhan

157 papers receiving 3.5k citations

Peers

Countries citing papers authored by Ping Zhan

Since Specialization

Citations

This map shows the geographic impact of Ping Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Zhan more than expected).

Fields of papers citing papers by Ping Zhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Zhan. The network helps show where Ping Zhan may publish in the future.

Co-authorship network of co-authors of Ping Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Zhan. A scholar is included among the top collaborators of Ping Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Zhan. Ping Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correction to: Efficacy and safety of anti‑PD‑1/PD‑L1‑based dual immunotherapies versus PD‑1/PD‑L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta‑analysis 2024 ·Cancer Immunology Immunotherapy ·Yueying Chen, Hedong Han, Jing Cheng, (unknown), Suhua Zhu, Ping Zhan, Hongbing Liu, Yong Song, Tangfeng Lv	1
2	Intervention Effect of Lower Limb Rehabilitation Robot with Task-Oriented Training on Stroke Patients and Its Influence on KFAROM Score 2024 ·Journal of Biosciences and Medicines ·(unknown), Li Huang, (unknown), (unknown), Ping Zhan, (unknown), Xia Gao, (unknown), Na Yin, (unknown), (unknown), Kaihua Tang	0
3	Lycorine combined with cisplatin synergistically inhibited osteosarcoma cells growth and metastasis by suppressing Wnt/β-Catenin and STAT3 signaling pathways 2024 ·Journal of Functional Foods ·(unknown), (unknown), Jia Feng, Ping Zhan, Qing Luo, (unknown)	0
4	Expression Profiles of Protease in Onychomycosis-Related Pathogenic Trichophyton rubrum and Tinea Capitis-Related Pathogenic Trichophyton violaceum 2024 ·Mycopathologia ·Jingjing Chen, (unknown), (unknown), (unknown), Ping Zhan	5
5	Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis 2024 ·Therapeutic Advances in Medical Oncology ·Jiayan Chen, Wanjun Lu, (unknown), (unknown), Ping Zhan, Xin Liu, Suhua Zhu, Mingxiang Ye, Tangfeng Lv, Jiawen Lv, Yong Song, Dong Wang	15
6	Efficacy and safety of anti-PD-1/PD-L1-based dual immunotherapies versus PD-1/PD-L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta-analysis 2024 ·Cancer Immunology Immunotherapy ·Yueying Chen, Hedong Han, Jing Cheng, (unknown), Suhua Zhu, Ping Zhan, Hongbing Liu, Yong Song, Tangfeng Lv	11
7	Neglected Adult Tinea Capitis in South China: A Retrospective Study in Nanchang, Jiangxi Province, from 2007 to 2021 2023 ·Mycopathologia ·(unknown), (unknown), (unknown), Qing Jiang, Rui Xu, Yunpeng Luo, (unknown), (unknown), Ping Zhan	1
8	Differential deuterolysin expression with a peak at low pH in human pathogenic fungiTrichophyton rubrumandT. mentagrophytes 2023 ·Medical Mycology ·Jingjing Chen, (unknown), (unknown), Ping Zhan	4
9	Inflammatory Bowel Disease and Rosacea: A Two‐Sample Mendelian Randomization Study 2023 ·Dermatologic Therapy ·Yunbo Wu, (unknown), Shiyu Chen, (unknown), (unknown), Ping Zhan, (unknown)	2
10	Nutritional requirements of the human pathogenic fungus, Trichophyton rubrum, and nutritional immunity of the human skin as barrier against colonization 2023 ·Fungal Biology Reviews ·(unknown), (unknown), Jingjing Chen, Alexandra Brand, Ping Zhan	2
11	Clinical impact of first‐line PD‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matched study 2023 ·Thoracic Cancer ·Jingyuan Xie, (unknown), Hedong Han, Ke Xu, (unknown), Xinqing Lin, Yong Song, Jinjun Ye, Tangfeng Lv, Ping Zhan	18
12	Zebrafish patient-derived xenografts accurately and quickly reproduce treatment outcomes in non–small cell lung cancer patients 2022 ·Experimental Biology and Medicine ·Xin Hua, (unknown), Ke Xu, Ping Zhan, Hongbing Liu, Fang Zhang, Tangfeng Lv, Yong Song	7
13	Overexpression of protein regulator of cytokinesis 1 facilitates tumor growth and indicates unfavorable prognosis of patients with colon cancer 2020 ·Cancer Cell International ·(unknown), Xiaoxia Wang, (unknown), (unknown), Junhua Li, Fengying Gao, Ping Zhan, (unknown)	8
14	Efficacy of rapid on-site evaluation for diagnosing pulmonary lesions and mediastinal lymph nodes: a systematic review and meta-analysis 2019 ·Translational Lung Cancer Research ·Xi Chen, (unknown), Yangyang Xu, (unknown), Ping Zhan, (unknown), Hongbing Liu, (unknown), Tangfeng Lv	13
15	Molecular epidemiology and in vitro antifungal susceptibility of Trichophyton schoenleinii, agent of tinea capitis favosa 2018 ·Mycoses ·(unknown), Ping Zhan, Ferry Hagen, Steph B. J. Menken, Jiufeng Sun, Ali Rezaei‐Matehkolaei, Sybren de Hoog	6
16	PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway 2017 ·Molecular Cancer ·Ping Zhan, Bin Zhang, Guangmin Xi, Ying Wu, Hongbing Liu, (unknown), Wujian Xu, Qingqing Zhu, Feng Cai, Zejun Zhou, (unknown), Xiaoxia Wang, Jiajia Jin, Qian Li, Liping Qian, Tangfeng Lv, Yong Song	93
17	Megestrol acetate in cancer patients with anorexia-cachexia syndrome: a meta-analysis 2013 ·Translational Cancer Research ·Ping Zhan, Qin Wang, Qian Qian, Li Yu	20
18	Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis 2013 ·Translational Cancer Research ·Ping Zhan, Qian Qian, Benjamin Wan, Tristan D. Yan, Yu Li	37
19	The effects of bisphenol A on sex hormone levels of F0 female rats and F1 male rats during weaning period 2010 ·Toxicological & Environmental Chemistry Reviews ·Bo Lü, Ping Zhan	4
20	A case-control analysis and laboratory study of the two feet-one hand syndrome in two dermatology hospitals in China 2009 ·Clinical and Experimental Dermatology ·Ping Zhan, Yiping Ge, (unknown), Xiaodong She, (unknown), (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact